Pharmacokinetics of colistin methanesulfonate and formed colistin in end-Stage renal disease patients receiving continuous ambulatory peritoneal dialysis
Colistin, administered intravenously as its inactive prodrug colistin methanesulfonate (CMS), is increasingly used as lastline therapy to combat multidrug-resistant Gram-negative bacteria. CMS dosing needs to be adjusted for renal function. The impact of continuous ambulatory peritoneal dialysis (CA...
Saved in:
Main Authors: | Pornpan Koomanachai, Cornelia B. Landersdorfer, Gong Chen, Hee Ji Lee, Anupop Jitmuang, Somkiat Wasuwattakul, Suchai Sritippayawan, Jian Li, Roger L. Nation, Visanu Thamlikitkul |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34734 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: Implications for dosing
by: Anupop Jitmuang, et al.
Published: (2018) -
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients
by: S. M. Garonzik, et al.
Published: (2018) -
Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai End-Stage Renal Disease Patients
by: Tanita Thaweethamcharoen, et al.
Published: (2020) -
Kidney Disease–Specific Scores and Health Utility of Continuous Ambulatory Peritoneal Dialysis Patients, Automated Peritoneal Dialysis Patients, and Caregivers
by: Tanita Thaweethamcharoen, et al.
Published: (2020) -
Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections
by: Rujipas Sirijatuphat, et al.
Published: (2018)